SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-005263
Filing Date
2020-01-17
Accepted
2020-01-17 21:48:43
Documents
1
Period of Report
2020-01-16

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 7142
  Complete submission text file 0001104659-20-005263.txt   8621
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 351 ROUSE BOULEVARD PHILADELPHIA PA 19112
Business Address
Norry Elliot (Reporting) CIK: 0001798117 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 20534922